报道称冠状病毒药物试验显示令人鼓舞的早期结果后，美股上涨，吉利德股价大涨15％。卫生保健刊物《STAT News》报道，芝加哥大学的3期药物试验发现，其大多数患者“发烧和呼吸道症状均迅速恢复”，并在不到一周的时间内出院。吉利德科学公司的R药显示出治疗冠状病毒的功效后，周四晚美国股市上涨。

如果人民的希望正式获批得到广泛应用的话，冠病就是一股流感而已。

美股几乎所有版块都被吉利德的好消息带动上涨，等一下新加坡股市开盘，请大家做好捡钱的准备。关键时刻，还是美帝拯救世界呀。

The 125 patients in a clinical trial of the drug all had severe respiratory symptoms and fever, but many were able to leave the hospital after less than a week of treatment, STAT quoted the doctor leading the trial as saying. However, the trial does not include what's known as a control group, so it will be difficult to say whether the drug is truly helping patients recover better. "The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," Dr. Kathleen Mullane, an infectious disease specialist at the University of Chicago who is leading the clinical trial, said in the video.

128个危重病人，一周不到就很多出院了，只死了两个，这就已经是神药了。危重病人一周就搞定出院，这对医疗资源是极大的利好。